Pharmacological inhibition of HIF2 protects against bone loss in an experimental model of estrogen deficiency is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology βHHS | National Institutes of Health
Grant: R01 AR073022-01A1
NIAMS NIH HHS
Grant: P30 AR069619
NIAMS NIH HHS
Grant: P30 AR069620
NIAMS NIH HHS
Grant: R01 AR073022
National Institutes of Health
Grant: 5R01AR073022-05
HIF-2alpha, a Novel Regulator of Osteoblastogenesis
National Institutes of Health
Grant: 5P30AR069620-05
Michigan Integrative Musculoskeletal Health Core Center (Resource-based Center)
FWCI
0.91
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals